EGR1 predicts PTEN and survival in patients with non-small-cell lung cancer.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Clinical Oncology

• Publication date

  2005-03-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2005.08.127PMID 15774784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer.

  2004cited by this paper
• Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer

  2004cited by this paper
• RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer.

  2004cited by this paper
• Egr1 Signaling in Prostate Cancer

  2003cited by this paper
• Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors

  2003cited by this paper
• In Vivo Cloning and Characterization of a New Growth Suppressor Protein TOE1 as a Direct Target Gene of Egr1*

  2003cited by this paper
• Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence

  2003cited by this paper
• A training-testing approach to the molecular classification of resected non-small cell lung cancer.

  2003cited by this paper
• RRM1-induced metastasis suppression through PTEN-regulated pathways

  2003cited by this paper
• Egr1 Transcription Factor: Multiple Roles in Prostate Tumor Cell Growth and Survival

  2002cited by this paper
• Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.

  2002cited by this paper
• Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas.

  2002cited by this paper
• Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array

  2002cited by this paper
• Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.

  2002cited by this paper
• Regulation of life and death by the zinc finger transcription factor Egr‐1

  2002cited by this paper
• The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling

  2001cited by this paper
• The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.

  2001cited by this paper
• Impaired prostate tumorigenesis in Egr1-deficient mice

  2001cited by this paper
• Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.

  2001cited by this paper
• EGR1 Target Genes in Prostate Carcinoma Cells Identified by Microarray Analysis*

  2000cited by this paper
• The Transcription Factor EGR-1 Directly Transactivates the Fibronectin Gene and Enhances Attachment of Human Glioblastoma Cell Line U251*

  2000cited by this paper
• Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.

  1999cited by this paper
• p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis

  1999cited by this paper
• The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-β1, Fibronectin, and Plasminogen Activator Inhibitor-1*

  1999cited by this paper
• New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.

  1999cited by this paper
• PTEN gene and integrin signaling in cancer.

  1999cited by this paper
• Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas.

  1999cited by this paper
• Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

  1998cited by this paper
• Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation.

  1998cited by this paper
• Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.

  1998cited by this paper
• Decreased Egr‐1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation

  1997cited by this paper
• Revisions in the International System for Staging Lung Cancer.

  1997cited by this paper
• Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group.

  1995cited by this paper
• Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain.

  1995cited by this paper
• Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.

  1994cited by this paper
• Cancer Cell International Inhibition of Cell Growth by Egr-1 in Human Primary Cultures from Malignant Glioma

  year unknowncited by this paper

• In vivo multiplexed modeling reveals diverse roles of the TBX2 subfamily and Egr1 in Kras-driven lung adenocarcinoma

  2025cites this paper
• Defensin-Rich Platelets Drive Pro-Tumorigenic Programs in Pancreatic Adenocarcinoma

  2025cites this paper
• Integration of Single-Cell and Bulk Transcriptomes to Identify a Poor Prognostic Tumor Subgroup to Predict the Prognosis of Patients with Early-stage Lung Adenocarcinoma

  2025cites this paper
• ceQTL: A co-expression QTL model to detect a variant that affects transcription factor binding and its target regulation

  2025cites this paper
• Nepicastat: a versatile therapeutic agent - pharmacological activities and clinical prospects.

  2025cites this paper
• KLK1 as an Epithelial‐Specific Brake Inhibits Colorectal Tumorigenesis by Suppressing B1R‐Mediated Fibroblast Phenotypic Transition

  2025cites this paper
• In Vivo Multiplexed Modeling Reveals Diverse Roles of the TBX2 Subfamily and Egr1 in Ras-Driven Lung Adenocarcinoma

  2025cites this paper
• MEK-mediated CHPF2 phosphorylation promotes colorectal cancer cell proliferation and metastasis by activating NF-κB signaling.

  2024cites this paper
• Abnormal expression of Krüppel-like transcription factors and their potential values in lung cancer

  2024cites this paper
• Mechanism of Sophorae Flavescentis Radix (Kushen) in treating NSCLC: Insights from miRNA-mRNA network analysis.

  2023cites this paper
• Differentiation-related genes in tumor-associated macrophages as potential prognostic biomarkers in non-small cell lung cancer

  2023cites this paper
• FZD1/KLF10-hsa-miR-4762-5p/miR-224-3p-circular RNAs axis as prognostic biomarkers and therapeutic targets for glioblastoma: a comprehensive report

  2023cites this paper
• Biological and Genetic Mechanisms of COPD, Its Diagnosis, Treatment, and Relationship with Lung Cancer

  2023cites this paper
• Fe3O4 Nanoparticles in Combination with 5-FU Exert Antitumor Effects Superior to Those of the Active Drug in a Colon Cancer Cell Model

  2023cites this paper
• Entamoeba histolytica HM-1: IMSS gene expression profiling identifies key hub genes, potential biomarkers, and pathways in Amoebiasis infection: a systematic network meta-analysis

  2022cites this paper
• Early Growth Response 1 Strengthens Pol-III-Directed Transcription and Transformed Cell Proliferation by Controlling PTEN/AKT Signalling Activity

  2022cites this paper
• Widespread perturbation of ETS factor binding sites in cancer

  2022cites this paper
• A novel meta-analysis based on data augmentation and elastic data shared lasso regularization for gene expression

  2022cites this paper
• Radix Sophorae Flavescentis (Kushen) inhibits NSCLC by targeting miR-183-5p/EGR1 and PTEN/AKt pathway

  2022cites this paper
• Early growth response-1 is a new substrate of the GSK3β-FBXW7 axis

  2022cites this paper
• NetTDP: permutation-based true discovery proportions for differential co-expression network analysis

  2022cites this paper
• The Role of the Transcription Factor EGR1 in Cancer

  2021cites this paper
• EGR1-CCL2 Feedback Loop Maintains Epithelial-Mesenchymal Transition of Cisplatin-Resistant Gastric Cancer Cells and Promotes Tumor Angiogenesis

  2021cites this paper
• Prognostic role of EGR1 in breast cancer: a systematic review

  2021cites this paper
• miR-377-3p-Mediated EGR1 Downregulation Promotes B[a]P-Induced Lung Tumorigenesis by Wnt/Beta-Catenin Transduction

  2021influential citation
• Molecular Cytogenetic Characterization of Synovial Sarcoma Cell Line SW982

  2021cites this paper
• Low EGR1 expression predicts poor prognosis in clear cell renal cell carcinoma.

  2021cites this paper
• Ring finger protein 2 promotes colorectal cancer progression by suppressing early growth response 1

  2020cites this paper
• Identification, Characterization, and Regulatory Mechanisms of a Novel EGR1 Splicing Isoform

  2019cites this paper
• The Mechanisms Underlying PTEN Loss in Human Tumors Suggest Potential Therapeutic Opportunities

  2019cites this paper
• Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network

  2018cites this paper
• Egr-1 is required for neu/HER2-induced mammary tumors.

  2018cites this paper
• EGR1 interacts with TBX2 and functions as a tumor suppressor in rhabdomyosarcoma

  2018cites this paper
• The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation

  2018cites this paper
• MiR-301b promotes the proliferation, mobility, and epithelial-to-mesenchymal transition of bladder cancer cells by targeting EGR1.

  2017cites this paper
• Upregulation of CISD2 augments ROS homeostasis and contributes to tumorigenesis and poor prognosis of lung adenocarcinoma

  2017cites this paper
• The Pseudogene DUXAP8 Promotes Non-small-cell Lung Cancer Cell Proliferation and Invasion by Epigenetically Silencing EGR1 and RHOB.

  2017cites this paper
• Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma

  2017cites this paper
• EGR1, EGFR and IGF1R protein expressions in non-small cell lung cancer and their clinical significances

  2016cites this paper
• EGR 1 , EGFR and IGF 1 R protein expressions in non-small cell lung cancer and their clinical significances

  2016influential citation
• PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection

  2016cites this paper
• PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature

  2016cites this paper
• Gene mutation characteristics of nonsmall-cell lung carcinoma patients with wild-type epidermal growth factor receptor and sensitivity to Tarceva therapy.

  2015cites this paper
• microRNA-181a enhances cell proliferation in acute lymphoblastic leukemia by targeting EGR1.

  2015cites this paper
• Network analysis of differentially expressed genes reveals key genes in small cell lung cancer.

  2015cites this paper
• Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.

  2015cites this paper
• AML1–ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia

  2014cites this paper
• Depletion of C3orf1/TIMMDC1 Inhibits Migration and Proliferation in 95D Lung Carcinoma Cells

  2014influential citation
• EGR1 decreases the malignancy of human non-small cell lung carcinoma by regulating KRT18 expression

  2014cites this paper
• P-REX2 PH Domain Inhibition of PTEN Regulates Transformation, Insulin Signaling, and Glucose Homeostasis

  2012cites this paper
• New insights into PTEN regulation mechanisms and its potential function in targeted therapies.

  2012cites this paper
• EGRI and FOSB gene expressions in cancer stroma are independent prognostic indicators for epithelial ovarian cancer receiving standard therapy

  2012cites this paper
• A gene signature distinguishing CD133hi from CD133− colorectal cancer cells: essential role for EGR1 and downstream factors

  2011cites this paper
• Functional genomics of microrna- directed regulation of tumorigenesis in human cancer cells

  2011cites this paper
• Clinical significance of tumor suppressor PTEN in colorectal carcinoma.

  2011cites this paper
• Integrated Systems and Technologies MicroRNA miR-183 Functions as an Oncogene by Targeting the Transcription Factor EGR 1 and Promoting Tumor Cell Migration

  2010cites this paper
• MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.

  2010cites this paper
• EGF-mediated regulation of EGR1 in prostate cancer cells.

  2010cites this paper
• Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma

  2010cites this paper
• Functional role of KLF10 in multiple disease processes

  2010cites this paper
• The Arf‐inducing transcription factor Dmp1 encodes a transcriptional activator of amphiregulin, thrombospondin‐1, JunB and Egr1

  2009cites this paper
• The PTEN/PI3 Kinase Pathway in Human Glioma

  2009cites this paper
• HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)

  2009influential citation
• rational use of cetuximab in the treatment of advanced non-small cell lung cancer

  2009cites this paper
• EGFR mutation up-regulates EGR1 expression through the ERK pathway.

  2009cites this paper
• Myelodysplastic syndromes: molecular pathogenesis and genomic changes

  2008cites this paper
• Advances in the treatment of acute myeloid leukemia: From chromosomal aberrations to biologically targeted therapy

  2008cites this paper
• Genome-wide transcriptional responses to acrolein.

  2008cites this paper
• PTEN in brain tumors

  2008cites this paper
• PTEN: its deregulation and tumorigenesis.

  2007cites this paper
• PI3 kinase/AKT pathway as a therapeutic target in multiple myeloma.

  2007cites this paper
• Immunohistochemical analysis of C/EBPα in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: A correlative study of E3590

  2007cites this paper
• Immunohistochemical analysis of C/EBPalpha in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: a correlative study of E3590.

  2007cites this paper
• Exposure to arsenic at levels found inU.S. drinking water modifies expression in the mouse lung.

  2007cites this paper
• Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders.

  2007cites this paper
• New insights into PTEN

  2007cites this paper
• Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer

  2007cites this paper
• Characteristics of expression of the genes of EGR1, neurotrophins, and their receptors in normal human lung tissues and lung cancers

  2007cites this paper
• Current development of mTOR inhibitors as anticancer agents

  2006cites this paper
• Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib

  2006cites this paper
• The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin

  2006cites this paper
• Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib.

  2006cites this paper
• Five loci, SLT1 to SLT5, controlling the susceptibility to spontaneously occurring lung cancer in mice.

  2005cites this paper
• Oncotargets and Therapy Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress Rational Use of Cetuximab in the Treatment of Advanced Non-small Cell Lung Cancer

  year unknowncites this paper